HOYA Vision Care Lights the Way with New Advances in Myopia Management at EAOO 2023

Poznań –16th May 2023 – HOYA Vision Care, a leader in optical technology innovation, participated as an official platinum sponsor at the European Academy of Optometry and Optics (EAOO) conference that took place 12-14 May 2023 in Poznań, Poland. During the conference, HOYA hosted a satellite symposium, Lighting the way: new evidence and advances in myopia management, where leading experts shared the latest results from clinical studies on MiYOSMART spectacle lenses and presented the new additions to the MiYOSMART portfolio MiYOSMART sun spectacle lenses.   


Dr Joanna Przeździecka-Dołyk of the Medical University of Wroclaw, Poland presented the results of an observational study that evaluated the acceptance, tolerance, everyday comfort, as well as the effectiveness of combination treatment of MiYOSMART spectacle lenses and low dose atropine drops in slowing down myopia progression in 68 European children.


Professor Giancarlo Montani of the University of Salento, Italy, highlighted the role of outdoor time and daylight in preventing myopia and slowing down its progression; and the importance of sun protection while children are spending more time outdoors.


Mr. Pascal Blaser, Global Medical Affairs Manager at HOYA Vision Care, presented the new MiYOSMART sun solutionsMiYOSMART Chameleon, photochromic spectacle lenses; and MiYOSMART Sunbird, polarized spectacle lenses – which will be rolled out in 30 countries worldwide during 2023. These two new products provide protection from intense sunlight, while simultaneously slowing down myopia progression using the same D.I.M.S. Technology used in MiYOSMART clear spectacle lenses1–7 shown to slow myopia progression by 60% in children aged 8 to 13.8


“We are proud to present the most recent data on MiYOSMART and introduce the new MiYOSMART sun solutions at EAOO. With the launch of MiYOSMART sun spectacle lenses, we can enable children across the world to spend more time outdoors without compromising their eyesight, so they can maximise the benefits of outdoor time and D.I.M.S. Technology on myopia progression,” said Dr May Zhang, Global Head of Professional Affairs at HOYA Vision Care.


Since its launch in 2018 until the end of 2022, over 4 million MiYOSMART spectacle lenses have been purchased by parents across the world.9 With the launch of MiYOSMART Chameleon and MiYOSMART Sunbird, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world.

“Together, we can tackle myopia in children”


About HOYA Vision Care

As a global leader in optical technology, HOYA Vision Care is dedicated to providing innovative vision care solutions for every stage of a patient’s life. A steadfast partner to Eye Care Professionals around the world, it stands at the forefront of optical excellence. With a global presence, consisting of 43 laboratories and a growing team of 20,000 employees, HOYA Vision Care delivers innovative lenses and other vision care solutions to millions of people in 110 countries.

About HOYA

For further information contact:

HOYA Vision Care PR

Susan Brown


Follow HOYA Vision Care on Linkedin


Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.



  1. 1. Hoya Vision Care, Report " Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and polarized lenses", 02/2023. Tests were conducted at room temperature (23°C).
  2. 2. HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022.
  3. 3. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
  4. 4. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
  5. 5. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484. Available at: https://iovs.arvojournals.org/article.aspx?articleid=2560920 (Last accessed 18/10/2022).
  6. 6. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/ (Last accessed 20/02/2023).
  7. 7. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225.
  8. 8. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.